Alok Sonig - Mar 1, 2023 Form 3 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Group President, Pharm
Signature
/s/ Matthew Rice, as attorney in-fact for Alok Sonig
Stock symbol
BAX
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
3
Date filed
3/3/2023, 03:02 PM
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BAX Common Stock, $1 par value 17.8K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BAX Stock Option (Right to Buy) Mar 1, 2023 Common Stock, $1 par value 25.6K $56.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on September 1, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2 The options become exercisable in three equal annual installments beginning on September 1, 2023, the first anniversary of the grant date.